AACI welcomes its newest and 100th member, Cold Spring Harbor Laboratory (CSHL) Cancer Center, one of seven National Cancer Institute-designated basic laboratory cancer centers.
Directed by David Tuveson, MD, PhD
, the CSHL Cancer Center is committed to exploring the fundamental biology of human cancer. Research at the center covers a broad range of cancer types, including breast, prostate, leukemia, brain, pancreatic, sarcoma, lung, and melanoma. Three scientific research programs provide focus in Gene Regulation & Cell Proliferation; Signal Transduction; and Cancer Genetics.
Founded in 1890 and located on Long Island, New York, the private, not-for-profit CSHL includes 54 laboratories, employing more than 1,100 people including 600 scientists, students and technicians. In addition to cancer, CSHL research areas include, neuroscience, plant biology and quantitative biology. CSHL serves as a major education institute, annually convening 12,000 scientists for meetings and advanced technology courses. As a basic research Cancer Center, CSHL Cancer Center members collaborate with local Northwell Health, New York’s largest healthcare provider, as well as other clinical centers to ensure cancer discoveries may be translated to the clinic.
The CSHL Cancer Center has nine shared resources that facilitate cancer research with state-of-the-art technology and integral services. With the support of world-class staff, these core facilities ensure that Cancer Center researchers have all the necessary tools to make breakthrough discoveries.
AACI’s other basic science centers are Sanford Burnham Prebys Medical Discovery Institute and Salk Institute for Biological Studies, both in California, Purdue Cancer Center (Indiana), Jackson Laboratory (Maine and Connecticut), and Wistar Institute (Pennsylvania).